Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-26 4:31 pm Sale | 2024-12-20 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 370,243 12.000% | -31,457 (-7.83%) | Filing History |
| 2024-11-14 7:24 pm Sale | 2024-09-30 | 13G | Scholar Rock Holding Corporation SRRK | ORBIMED ADVISORS LLC | 503,400 0.600% | -2,456,600 (-82.99%) | Filing History |
| 2024-11-14 7:22 pm Sale | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 0 0.000% | -2,255,000 (Position Closed) | Filing History |
| 2024-11-14 6:45 pm Sale | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 2,441,275 4.000% | -558,725 (-18.62%) | Filing History |
| 2024-11-14 6:43 pm Purchase | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | ORBIMED ADVISORS LLC | 2,925,900 4.200% | 2,925,900 (New Position) | Filing History |
| 2024-11-14 6:41 pm Purchase | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ORBIMED ADVISORS LLC | 589,200 4.900% | 589,200 (New Position) | Filing History |
| 2024-11-14 6:35 pm Unchanged | 2024-09-30 | 13G | InspireMD, Inc. NSPR | ORBIMED ADVISORS LLC | 2,133,405 8.300% | 0 (Unchanged) | Filing History |
| 2024-11-14 6:30 pm Sale | 2024-09-30 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 3,406,335 11.700% | -597,632 (-14.93%) | Filing History |
| 2024-11-14 6:25 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 4,148,862 9.900% | 2,619,747 (+171.32%) | Filing History |
| 2024-11-14 6:23 pm Purchase | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | ORBIMED ADVISORS LLC | 967,000 9.900% | 967,000 (New Position) | Filing History |
| 2024-11-12 6:04 pm Unchanged | 2024-11-07 | 13D | Third Harmonic Bio, Inc. THRD | ORBIMED ADVISORS LLC | 5,779,071 12.800% | 0 (Unchanged) | Filing History |
| 2024-11-12 5:23 pm Unchanged | 2024-11-07 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 14,756,096 15.600% | 0 (Unchanged) | Filing History |
| 2024-11-08 7:15 pm Purchase | 2024-11-01 | 13D | Lomond Therapeutics Holdings, Inc. | ORBIMED ADVISORS LLC | 2,677,256 9.800% | 2,677,256 (New Position) | Filing History |
| 2024-11-06 4:12 pm Purchase | 2024-09-16 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 605,531 19.900% | 3,531 (+0.59%) | Filing History |
| 2024-10-25 4:24 pm Sale | 2024-10-23 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 1,182,717 4.800% | -941,550 (-44.32%) | Filing History |
| 2024-10-17 4:16 pm Purchase | 2024-10-15 | 13D | Upstream Bio, Inc. UPB | ORBIMED ADVISORS LLC | 4,554,873 8.900% | 4,554,873 (New Position) | Filing History |
| 2024-10-01 5:35 pm Sale | 2024-09-27 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,124,267 8.600% | -313,700 (-12.87%) | Filing History |
| 2024-09-23 6:44 pm Purchase | 2024-09-16 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 602,000 19.900% | 602,000 (New Position) | Filing History |
| 2024-09-23 4:34 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | ORBIMED ADVISORS LLC | 3,812,215 12.000% | 3,812,215 (New Position) | Filing History |
| 2024-09-16 8:29 pm Unchanged | 2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,562,971 9.000% | 0 (Unchanged) | Filing History |